关注
Mohamed E. E. Shams
Mohamed E. E. Shams
Professor and Head of Dept. of Clinical Pharmacy, Faculty of Pharmacy, Mansoura University
在 mans.edu.eg 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
CYP2D6 polymorphism and clinical effect of the antidepressant venlafaxine
S ME, A B, H C, D A, HS Müller
Journal of Clinical Pharmacy and Therapeutics 31 (5), 493-502, 2006
3032006
Metabolomics of type 1 and type 2 diabetes
B Arneth, R Arneth, M Shams
International journal of molecular sciences 20 (10), 2467, 2019
2322019
The clinical and cost effectiveness of bee honey dressing in the treatment of diabetic foot ulcers
AM Moghazy, ME Shams, OA Adly, AH Abbas, MA El-Badawy, ...
Diabetes research and clinical practice 89 (3), 276-281, 2010
1592010
Measuring the rate of therapeutic adherence among outpatients with T2DM in Egypt
MEE Shams, EAME Barakat
Saudi Pharmaceutical Journal 18 (4), 225-232, 2010
1532010
Adherence to medication among outpatient adolescents with epilepsy
WM Gabr, MEE Shams
Saudi Pharmaceutical Journal 23 (1), 33-40, 2015
1502015
Inflammation and psychotropic drugs: the relationship between C-reactive protein and antipsychotic drug levels
G Hefner, MEE Shams, S Unterecker, T Falter, C Hiemke
Psychopharmacology 233, 1695-1705, 2016
932016
Type 2 diabetes mellitus-induced hyperglycemia in patients with NAFLD and normal LFTs: relationship to lipid profile, oxidative stress and pro-inflammatory cytokines
MEE Shams, MMH Al-Gayyar, EAME Barakat
Scientia pharmaceutica 79 (3), 623-634, 2011
752011
Collection, storage and use of blood samples for future research: views of Egyptian patients expressed in a cross-sectional survey
A Abou-Zeid, H Silverman, M Shehata, M Shams, M Elshabrawy, ...
Journal of medical ethics 36 (9), 539-547, 2010
612010
Protective effects of arjunolic acid against cardiac toxicity induced by oral sodium nitrite: effects on cytokine balance and apoptosis
MMH Al-Gayyar, A Al Youssef, IO Sherif, MEE Shams, A Abbas
Life sciences 111 (1-2), 18-26, 2014
492014
Phenotyping and genotyping of drug metabolism to guide pharmacotherapy in psychiatry
C Hiemke, M Shams
Current drug delivery 10 (1), 46-53, 2013
412013
Melperone is an inhibitor of the CYP2D6 catalyzed O-demethylation of venlafaxine
M Grözinger, A Dragicevic, C Hiemke, M Shams, MJ Müller, S Härtter
Pharmacopsychiatry 36 (01), 3-6, 2003
382003
Therapeutic drug monitoring of the antidepressant mirtazapine and its N-demethylated metabolite in human serum
M Shams, C Hiemke, S Härtter
Therapeutic drug monitoring 26 (1), 78-84, 2004
362004
Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: impact of nonalcoholic fatty liver disease
MMH Al-Gayyar, MEE Shams, EAME Barakat
Pharmaceutical Biology 50 (3), 297-303, 2012
342012
Paroxetine serum concentrations in depressed patients and response to treatment.
HC Gilles M, Deuschle M, Kellner S, Shams M, Krumm B
Pharmacopsychiatry 38 (3), 118-121, 2005
342005
Thymoquinone therapy remediates elevated brain tissue inflammatory mediators induced by chronic administration of food preservatives
AM Hamdan, MM Al-Gayyar, MEE Shams, US Alshaman, K Prabahar, ...
Scientific reports 9 (1), 7026, 2019
322019
Rapid and reliable genotyping procedure for detection of alleles with mutations, deletion, or/and duplication of the CYP2D6 gene
B Arneth, M Shams, C Hiemke, S Härtter
Clinical biochemistry 42 (12), 1282-1290, 2009
302009
Rating the delirogenic potential of drugs for prediction of side effects in elderly psychiatric inpatients
G Hefner, M Shams, K Wenzel-Seifert, A Fellgiebel, T Falter, E Haen, ...
JJ Pharma Pharmacovigilance 1 (1), 003, 2015
202015
Melperone but not bisoprolol or metoprolol is a clinically relevant inhibitor of CYP2D6: evidence from a therapeutic drug monitoring survey
G Hefner, S Unterecker, MEE Shams, M Wolf, T Falter, E Haen, C Hiemke
Journal of Neural Transmission 122, 1609-1617, 2015
182015
Retrospective pilot study for analysis of antidepressant serum concentrations of citalopram and venlafaxine during inflammation
G Hefner, MEE Shams, S Unterecker, T Falter, C Hiemke
Pharmacopsychiatry 25 (06), 215-218, 2015
102015
Measuring serum levels of glycosaminoglycans for prediction and using viscum fraxini-2 for treatment of patients with hepatocellular carcinoma
MEES Mohammed M.H. Al-Gayyara, Mohamed A. Ebrahim
Journal of Pharmacy Research, 2013
82013
系统目前无法执行此操作,请稍后再试。
文章 1–20